The gut-liver axis model has helped to explain the liver steatosis (NAFLD) and steatohepatitis (NASH) etiopathogenesis. The discovery of a key role for an altered intestinal permeability (IP) in this pathophysioligcal framework has closed the link between gut lumen antigenic/toxic substances and systemic and liver inflammation in NAFLD and obesity, metabolic syndrome. Recent evidence from the literature show how IP can be modulated by several non-pharmacological and pharmacological agents and be the target for future preventive and curative treatment of NAFLD and NASH. In this review we describe the concept of IP, its ultrastructural basis, its role in the NALFD pathophysiology and emerging evidence on non-pharmacological and pharmacological agents able to favourably modulate it.

Intestinal Permeability In Non-Alcoholic Fatty Liver Disease: The Gut-Liver Axis / Scarpellini, Emidio; Lupo, Marinella; Iegri, Claudia; Antonio, Gasbarrini; DE SANTIS, Adriano; Jan, Tack. - In: REVIEWS ON RECENT CLINICAL TRIALS. - ISSN 1574-8871. - STAMPA. - 9:(2014), pp. 141-147. [10.2174/1574887109666141216104334]

Intestinal Permeability In Non-Alcoholic Fatty Liver Disease: The Gut-Liver Axis.

SCARPELLINI, EMIDIO;LUPO, MARINELLA;IEGRI, CLAUDIA;DE SANTIS, Adriano;
2014

Abstract

The gut-liver axis model has helped to explain the liver steatosis (NAFLD) and steatohepatitis (NASH) etiopathogenesis. The discovery of a key role for an altered intestinal permeability (IP) in this pathophysioligcal framework has closed the link between gut lumen antigenic/toxic substances and systemic and liver inflammation in NAFLD and obesity, metabolic syndrome. Recent evidence from the literature show how IP can be modulated by several non-pharmacological and pharmacological agents and be the target for future preventive and curative treatment of NAFLD and NASH. In this review we describe the concept of IP, its ultrastructural basis, its role in the NALFD pathophysiology and emerging evidence on non-pharmacological and pharmacological agents able to favourably modulate it.
2014
gut-liver axis NAFLD intestinal permeability
01 Pubblicazione su rivista::01a Articolo in rivista
Intestinal Permeability In Non-Alcoholic Fatty Liver Disease: The Gut-Liver Axis / Scarpellini, Emidio; Lupo, Marinella; Iegri, Claudia; Antonio, Gasbarrini; DE SANTIS, Adriano; Jan, Tack. - In: REVIEWS ON RECENT CLINICAL TRIALS. - ISSN 1574-8871. - STAMPA. - 9:(2014), pp. 141-147. [10.2174/1574887109666141216104334]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/656018
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 32
  • ???jsp.display-item.citation.isi??? ND
social impact